18-26274687-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005640.3(TAF4B):c.622G>A(p.Val208Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,461,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005640.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF4B | NM_005640.3 | c.622G>A | p.Val208Ile | missense_variant | 4/15 | ENST00000269142.10 | NP_005631.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF4B | ENST00000269142.10 | c.622G>A | p.Val208Ile | missense_variant | 4/15 | 1 | NM_005640.3 | ENSP00000269142 | P4 | |
TAF4B | ENST00000578121.5 | c.622G>A | p.Val208Ile | missense_variant | 4/15 | 2 | ENSP00000462980 | A2 | ||
TAF4B | ENST00000418698.3 | c.622G>A | p.Val208Ile | missense_variant, NMD_transcript_variant | 4/16 | 5 | ENSP00000389365 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249124Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135136
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.622G>A (p.V208I) alteration is located in exon 4 (coding exon 4) of the TAF4B gene. This alteration results from a G to A substitution at nucleotide position 622, causing the valine (V) at amino acid position 208 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at